Aquisição de Cisplatina 1 mg/ml sol inj fr 100 ml IV, Cisplatina 1 mg/ml sol inj fr 50 ml IV, Icatibant 30 mg/3 ml sol inj ser 3 ml SC, Oxaliplatina 5 mg/ml sol inj fr 40 ml IV e Pertuzumab 60 mg/ml + Trastuzumab 60 mg/ml sol inj fr 10 ml SC

ID 11666422 · Portal BASE
Price
Base Price
€73,063 .00
Effective Price
€27,780 .00 -62.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ao abrigo de acordo-quadro (art.º 259.º)
CPV Code
33600000
Location
Portugal, Lisboa, Lisboa
Bidder Count
—
Winner
FRESENIUS KABI PHARMA PORTUGAL LDA
NIF 504293753
Company
Dates
Publication
28 Aug 2025
Celebration
21 Aug 2025
Contracting Entity
Centro Hospitalar Universitário Lisboa Central, EPE
NIF 508080142
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 45 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
73063.0
Threshold
75000.0
Rule
A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
73063.0
Total effective price
27780.0
Ratio
0.3802
Direction
reduction
Rule
A9 price reduction: ratio 0.3802 outside [0.5, 1.5]
Detected 2026-03-06